BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16398319)

  • 1. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
    Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
    Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.
    Shokrollahi K; Javed M; Aeuyung K; Ghattaura A; Whitaker IS; O'Leary B; James W; Murison M
    Ann Plast Surg; 2014 Nov; 73(5):552-8. PubMed ID: 23407256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
    Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
    Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
    Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
    Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
    Gómez C; Cobos P; Alberdi E
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102176. PubMed ID: 33429099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of eyelid basal cell carcinoma.
    Kotimäki J
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1083-7. PubMed ID: 19470065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
    Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
    Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
    Wiegell SR; Skødt V; Wulf HC
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
    Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.
    Venturini M; Sala R; Gonzàlez S; Calzavara-Pinton PG
    Br J Dermatol; 2013 Jan; 168(1):99-105. PubMed ID: 23013443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.
    Guleng GE; Helsing P
    Clin Exp Dermatol; 2012 Jun; 37(4):367-9. PubMed ID: 22420420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
    de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
    Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.